Aclaris Therapeutics Balance Sheet (2014-2026) | ACRS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)	3.04M	3.21M	3.39M	3.54M	3.70M	3.87M	4.04M	4.21M	4.41M	4.60M	4.16M	4.34M	4.52M	4.68M	4.80M	4.91M	5.01M	4.98M
Assets
Current Assets
Cash & Equivalents (Quarter)	113.45M	53.60M	27.35M	36.34M	68.26M	61.65M	45.28M	44.72M	31.15M	39.04M	39.88M	35.84M	22.83M	47.65M	24.57M	30.36M	25.40M	25.26M	19.96M	28.66M
Receivables - Net (Quarter)	0.94M	0.81M	0.62M	0.63M	0.64M	0.60M	0.48M	0.69M	0.43M	0.35M	0.30M	0.37M	0.70M	0.34M	0.32M	0.25M	0.19M
Receivables - Other (Quarter)			0.02M
Receivables (Quarter)	0.94M	0.81M	0.65M	0.63M	0.64M	0.60M	0.48M	0.69M	0.43M	0.35M	0.30M	0.37M	0.70M	0.34M	0.32M	0.25M	0.19M
Inventory (Quarter)
Prepaid Assets (Quarter)	8.65M	7.09M	12.99M	10.63M	10.11M	7.91M	13.49M	12.87M	12.73M	19.67M	9.45M	6.80M	6.22M	4.26M	12.04M	3.23M	4.20M
Current Assets (Quarter)	241.26M	205.78M	205.03M	190.88M	259.35M	256.57M	231.55M	184.36M	132.94M	123.07M	128.86M	135.34M	117.64M	132.33M	125.95M	108.79M	104.20M	100.59M	96.32M	110.23M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.29M	1.17M	1.33M	1.28M	1.28M	1.15M	1.10M	1.51M	1.90M	1.76M	1.62M	1.53M	1.29M	1.13M	1.01M	0.94M	0.87M	0.81M	0.76M	0.75M
Long-Term Investments (Quarter)	34.50M	45.73M	34.24M	23.95M	7.22M		12.24M	33.60M	90.99M	83.94M	62.77M	33.20M	38.78M	45.71M	90.30M	85.21M	81.08M	71.30M	60.61M	85.37M
Goodwill (Quarter)
Intangibles (Quarter)	7.09M	7.38M	7.38M	7.03M	7.01M	6.99M	7.38M	6.95M	6.93M	6.92M	0.27M
Goodwill & Intangibles (Quarter)	7.09M	7.38M	7.38M	7.03M	7.01M	6.99M	7.38M	6.95M	6.93M	6.92M	0.27M
Other Non-Current Assets (Quarter)	3.91M	3.74M	3.55M	3.38M	3.11M	2.92M	2.73M	3.27M	2.89M	2.66M	4.16M	4.00M	3.37M	3.22M	3.07M	3.15M	2.99M	2.83M	2.77M	2.37M
Non-Current Assets (Quarter)	46.78M	57.71M	46.18M	35.65M	18.62M	11.06M	23.05M	45.34M	102.71M	95.29M	68.55M	38.73M	43.44M	50.06M	94.38M	89.30M	84.94M	74.94M	64.14M	88.49M
Assets (Quarter)	288.05M	263.49M	251.21M	226.53M	277.98M	267.63M	254.60M	229.71M	235.65M	218.35M	197.41M	174.06M	161.07M	182.39M	220.33M	198.09M	189.15M	175.53M	160.46M	198.72M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.24M	7.56M	9.98M	8.12M	5.70M	7.67M	10.35M	8.19M	11.43M	9.65M	8.88M	10.81M	7.27M	7.66M	4.69M	6.35M	8.80M	9.19M	13.16M	14.73M
Payables (Quarter)	4.24M	7.56M	9.98M	8.12M	5.70M	7.67M	10.35M	8.19M	11.43M	9.65M	8.88M	10.81M	7.27M	7.66M	4.69M	6.35M	8.80M	9.19M	13.16M	14.73M
Accumulated Expenses (Quarter)	1.92M	7.41M	4.39M	5.69M	2.88M	3.83M	8.70M	7.26M	3.90M	15.16M	19.45M	6.57M	1.14M	0.50M	4.98M	1.73M	2.74M	9.78M	8.79M	2.04M
Other Accumulated Expenses (Quarter)	0.65M	0.61M	1.73M	0.72M	1.92M	1.74M	0.22M	0.57M	0.75M	0.56M	0.28M	2.71M	2.65M	0.41M	0.61M	2.70M	2.72M	0.39M	0.50M	0.66M
Short term Debt (Quarter)
Current Leases (Quarter)			0.69M		0.74M	0.77M	0.68M	0.60M	0.46M	0.31M	0.43M
Current Deferred Revenue (Quarter)													25.80M	3.77M	3.89M	3.89M	3.91M	3.92M	3.94M	3.97M
Total Current Liabilities (Quarter)	14.92M	17.84M	22.93M	16.73M	16.22M	19.79M	21.94M	18.26M	22.83M	27.32M	30.95M	20.08M	15.68M	18.82M	31.60M	21.51M	26.84M	25.63M	28.64M	27.37M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)														21.18M	20.04M	19.21M	18.22M	17.49M	16.17M	15.29M
Preferred Stock Liabilities (Quarter)
Liabilities from Discontinued Operations (Quarter)	3.09M	2.20M	2.20M	2.20M	2.20M	2.20M	2.20M	2.20M	2.20M	2.20M	2.20M
Non-Current Deferred Tax Liability (Quarter)	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M	0.37M
Other Non-Current Liabilities (Quarter)	2.92M	2.51M	28.40M	27.20M	23.80M	1.64M	33.10M	32.30M	30.80M	32.50M	6.20M	9.00M	2.37M	10.00M	8.70M	4.31M	10.50M	1.71M	11.00M	11.00M
Total Non-Current Liabilities (Quarter)	51.31M	44.41M	25.47M	19.13M	18.42M	46.16M	23.88M	20.60M	25.10M	29.52M	34.03M	23.05M	24.88M	42.24M	56.07M	49.72M	46.91M	53.72M	46.38M	44.07M
Total Liabilities (Quarter)	54.23M	46.91M	53.87M	46.33M	42.22M	47.79M	56.98M	52.90M	55.90M	62.02M	40.23M	32.05M	27.25M	52.24M	64.77M	54.03M	57.41M	55.43M	57.38M	55.07M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	233.81M	216.58M	197.34M	180.20M	235.75M	219.84M	197.62M	176.81M	179.75M	156.33M	157.18M	142.01M	133.82M	130.15M	155.55M	144.07M	131.74M	120.10M	103.08M	143.65M
Shareholder's Equity (Quarter)	233.81M	216.58M	197.34M	180.20M	235.75M	219.84M	197.62M	176.81M	179.75M	156.33M	157.18M	142.01M	133.82M	130.15M	155.55M	144.07M	131.74M	120.10M	103.08M	143.65M
Liabilities and Shareholders Equity (Quarter)	288.05M	263.49M	251.21M	226.53M	277.98M	267.63M	254.60M	229.71M	235.65M	218.35M	197.41M	174.06M	161.07M	182.39M	220.33M	198.09M	189.15M	175.53M	160.46M	198.72M
Retained Earnings (Quarter)	-551.50M	-0.00M	-0.22M	-0.97M	-634.73M	-1.47M	-0.90M	-710.48M	-1.11M	-769.30M	-0.11M	-787.70M	-798.70M	0.43M	0.10M	-917.95M	0.48M	-948.00M	-967.78M	0.02M
Treasury Shares (Quarter)	0.02M	1.46M	1.49M	0.01M	1.45M	1.59M	1.52M	1.74M	1.72M	1.71M	1.52M	3.14M	3.11M	3.07M	0.18M	3.17M	0.07M	3.10M	2.18M	1.46M
Shares Outstanding (Quarter)	8.10M	61.23M	61.23M	61.74M	66.67M	66.68M	66.69M	67.21M	70.77M	70.82M	70.89M	71.25M	71.33M	71.42M	107.85M	108.27M	108.33M	108.34M	120.50M	139.65M

Research Tools

Developers

Aclaris Therapeutics Balance Sheet (2014-2026) | ACRS

Research Tools

Developers

Aclaris Therapeutics Balance Sheet (2014-2026) | ACRS

Create an account

Sign In

Reset Password